Lysosomal alpha-N-acetylgalactosaminidase deficiency: a new inherited metabolic disease.
1987
O P van Diggelen, and
D Schindler, and
W J Kleijer, and
J M Huijmans, and
H Galjaard, and
H U Linden, and
J Peter-Katalinic, and
H Egge, and
U Dabrowski, and
M Cantz
UI
MeSH Term
Description
Entries
D008297
Male
Males
D002239
Carbohydrate Metabolism, Inborn Errors
Dysfunctions of CARBOHYDRATE METABOLISM resulting from inborn genetic mutations that are inherited or acquired in utero.
Carbohydrate Metabolism, Inborn Error
D002675
Child, Preschool
A child between the ages of 2 and 5.
Children, Preschool,Preschool Child,Preschool Children
D006596
Hexosaminidases
Enzymes that catalyze the hydrolysis of N-acylhexosamine residues in N-acylhexosamides. Hexosaminidases also act on GLUCOSIDES; GALACTOSIDES; and several OLIGOSACCHARIDES.
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D048809
alpha-N-Acetylgalactosaminidase
A hexosaminidase with specificity for terminal non-reducing N-acetyl-D-galactosamine residues in N-acetyl-alpha-D-galactosaminides.
alpha-N-Acetyl-D-galactosaminidase,N-Acetyl-alpha-D-Galactosaminidase,alpha-D-N-Acetyl-Galactosaminyloligosaccharidase,alpha-D-N-Acetylgalactosaminyloligosaccharidase,alpha-Galactosidase B,endo-N-Acetyl-alpha-D-Galactosamidase,endo-alpha-N-Acetylgalactosaminidase,N Acetyl alpha D Galactosaminidase,alpha D N Acetyl Galactosaminyloligosaccharidase,alpha D N Acetylgalactosaminyloligosaccharidase,alpha Galactosidase B,alpha N Acetyl D galactosaminidase,alpha N Acetylgalactosaminidase,endo N Acetyl alpha D Galactosamidase,endo alpha N Acetylgalactosaminidase
Related Publications
O P van Diggelen, and
D Schindler, and
W J Kleijer, and
J M Huijmans, and
H Galjaard, and
H U Linden, and
J Peter-Katalinic, and
H Egge, and
U Dabrowski, and
M Cantz
O P van Diggelen, and
D Schindler, and
W J Kleijer, and
J M Huijmans, and
H Galjaard, and
H U Linden, and
J Peter-Katalinic, and
H Egge, and
U Dabrowski, and
M Cantz
January 1990,
Journal of inherited metabolic disease,
O P van Diggelen, and
D Schindler, and
W J Kleijer, and
J M Huijmans, and
H Galjaard, and
H U Linden, and
J Peter-Katalinic, and
H Egge, and
U Dabrowski, and
M Cantz
O P van Diggelen, and
D Schindler, and
W J Kleijer, and
J M Huijmans, and
H Galjaard, and
H U Linden, and
J Peter-Katalinic, and
H Egge, and
U Dabrowski, and
M Cantz
O P van Diggelen, and
D Schindler, and
W J Kleijer, and
J M Huijmans, and
H Galjaard, and
H U Linden, and
J Peter-Katalinic, and
H Egge, and
U Dabrowski, and
M Cantz
August 1991,
The Journal of clinical investigation,
O P van Diggelen, and
D Schindler, and
W J Kleijer, and
J M Huijmans, and
H Galjaard, and
H U Linden, and
J Peter-Katalinic, and
H Egge, and
U Dabrowski, and
M Cantz
O P van Diggelen, and
D Schindler, and
W J Kleijer, and
J M Huijmans, and
H Galjaard, and
H U Linden, and
J Peter-Katalinic, and
H Egge, and
U Dabrowski, and
M Cantz
September 1995,
Journal of the neurological sciences,
O P van Diggelen, and
D Schindler, and
W J Kleijer, and
J M Huijmans, and
H Galjaard, and
H U Linden, and
J Peter-Katalinic, and
H Egge, and
U Dabrowski, and
M Cantz
February 2007,
Journal of inherited metabolic disease,
O P van Diggelen, and
D Schindler, and
W J Kleijer, and
J M Huijmans, and
H Galjaard, and
H U Linden, and
J Peter-Katalinic, and
H Egge, and
U Dabrowski, and
M Cantz
O P van Diggelen, and
D Schindler, and
W J Kleijer, and
J M Huijmans, and
H Galjaard, and
H U Linden, and
J Peter-Katalinic, and
H Egge, and
U Dabrowski, and
M Cantz